Sleep Quality & Psoriatic Arthritis
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
Read more →What's hot
View all perspectives
What's Hot
Ultrasound in PsA
Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Watch video →
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Watch video →
Sunday (Day 2): ACR 22 Daily Recap
ACR 2022 Daily Recap for Sunday, November 13th. Panelists: Drs. Robert Chao, Antoni Chan, Bella Mehta, Janet Pope, Yuz Yusof, Cassy Sims, Akhil Sood, Sheila Reyes and Jack Cush.
Watch video →
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Watch video →
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Watch video →
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Watch video →
PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Watch video →
ACR22 Daily Recap: Saturday Recap
Panelists: Drs. Jack Cush, Michael Putman, Eric Dein, Patricia Harkins and Rachel Tate.
Watch video →
Robert B Chao, MD doctorRBC
3 years 1 month ago
Very important point about statin induced myopathy by Dr. Christopher-Stine.
If 1) history of statin exposure, 2) typical symptoms of myositis 3) HMGCR ab positive — do NOT need biopsy and can treat as statin associated necrotizing autoimmune myopathy!
@RheumNow #ACR22 https://t.co/VHxPRkCWwj
Dr. Rachel Tate uptoTate
3 years 1 month ago
Among ANCA-vasculitis hospitalizations, A Fib found to be most common CV condition. Females had fewer CV complications, lower in-hospital mortality & shorter length of stay compared to males. Abs 0434 #ACR22 https://t.co/2IikApUdvE https://t.co/16ggVScs3a
Dr. Rachel Tate uptoTate
3 years 1 month ago
SELECT-AXIS 2 subgroup analysis. UPA demonstrated improved efficacy vs PBO at Wk 14 across all evaluated subgroups of pts with bDMARD-IR AS. No new safety signals. @XBaraliakos et al, Abs 0414 #ACR22 https://t.co/lTfm68XlEY https://t.co/PaWdrOljMO
Dr. Rachel Tate uptoTate
3 years 1 month ago
Do you check ANCAs in your ILD pts? Abs 0438 at #ACR22 suggests you should! @RheumNow
https://t.co/W8rRAdWFQh https://t.co/RQfcQQUVzI
Mike Putman EBRheum
3 years 1 month ago
Headed to the #ACR22 Fellows in Training (FIT) session for a round table on keeping up with the medical literature!
As usual, updated handout for this year 🤓
@MithuRheum Wish I had thought to ask you for help w/my graphics-game! Not my strength hahaha
#ACRAmbassador https://t.co/Tg4ZT262rU
Mike Putman EBRheum
3 years 1 month ago
Very cool initiative @Robsonjo4
1. I love patient reported outcomes (PROs)
2. I think we under-appreciate how much steroids affect our patients quality of life
Looking forward to seeing this live!
#ACR22 #Vasculitis22 @RheumNow https://t.co/1akO1k7VgU
Mike Putman EBRheum
3 years 1 month ago
Interesting study about causes of death in GCA
I never know what to make of these; our pts typically die of the usual things (cancer, CVD) and have increased risks of infection (due to treatment)
Is there USA data about this?
#ACRAmbassador #ACR22 https://t.co/ZMOSD7lYGL
TheDaoIndex KDAO2011
3 years 1 month ago
Regional Winners (people's choice award goes to North America tumoral calcinosis) #ACR22 Image Competition @rheumnow https://t.co/y7dDHc75PQ
TheDaoIndex KDAO2011
3 years 1 month ago
“I don’t live in an igloo, I don’t have a dog sled, and yes we do have daylight some times of the year – Dr. John Botson (from Alaska) answering questions on everyone's mind before he presented the MIRROR RCT study #Plenary1 #ACR22 @rheumnow https://t.co/y23Keeh3r8
Catherine Sims, MD DrCassySims
3 years 1 month ago
What has changed since the 2020 @ACRheum #reproductive guidelines?
Abstract #1717 425 SLE/RA patients:
📍 significant improvement in pre-#pregnancy counseling and discussions in reproductive goals
📍No improvements in birth control use or documentation
TheDaoIndex KDAO2011
3 years 1 month ago
#RheumPearls: Check APLs in all SLE pts because they influences contraceptive choice, postpartum/surgery anticoag prophylx, and HRT counseling
Dr. J Kolfenbach #ACR22 @rheumnow https://t.co/Hnrh4NhmBj
Leonard Calabrese LCalabreseDO
3 years 1 month ago
We share our vision of what rheumatologists should be considering thinking and doing regarding COVID-19 in our immunocompromise patients. Would love your reactions @CCalabreseDO @BetsyKirch @DrPujaMehta1 @alhkim @drdavidliew @philipcrobinson #ACR22 https://t.co/OpmoEOXWmL
Richard Conway RichardPAConway
3 years 1 month ago
This year, as every year, at ACR (and EULAR) I am amazed by some of what are oral presentations vs what is in the posters. Please check out the poster sessions, there are some absolute gems in there! I will amplify the ones I find that I feel competent to discuss #ACR22
Dr. Antoni Chan synovialjoints
3 years 1 month ago
Primary care provider education can improve rheumatology care:
➤ Post-training ratings in confidence and knowledge improved compared to baseline
➤ Gives me confidence for my own local programme RheumACaN for GPs,PCPs
Mandal J 0005 https://t.co/MCb7QTcYsL #ACR22 @RheumNow https://t.co/sTYFtbbvtT
sheila RHEUMarampa
3 years 1 month ago
HCQ tx thresholds study by Prof Garg:
🔸HCQ >=500ng/ml: good threshold to detect adherence
🔸HCQ 750-1000ng/ml: effective thresholds to prevent flares
🔸CKD>=2: 4x ⬆️odds of HCQ>1500ng/ml (supraTx! dose adj.)
Interesting data.
Game changing?🧐
#ACR22 @RheumNow ABST#0344 #ACRBest https://t.co/GxlucrTeE5
Poster Hall